Cargando…
High tumour burden, delayed diagnosis and history of cardiovascular disease may be associated with carcinoid heart disease
BACKGROUND: Patients with carcinoid syndrome (CS) may present carcinoid heart disease (CHD) but prognostic factors are not entirely understood. PATIENTS AND METHODS: Retrospective study of patients with metastatic neuroendocrine tumours (NETs) and CS and/or abnormal 24-hour-urinary 5-hydroxiindolace...
Autores principales: | Alves, Carolina, Mesquita, Marcella, Silva, Carolina, Soeiro, Maria, Hajjar, Ludhmila, Riechelmann, Rachel P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cancer Intelligence
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6214675/ https://www.ncbi.nlm.nih.gov/pubmed/30483359 http://dx.doi.org/10.3332/ecancer.2018.879 |
Ejemplares similares
-
Synoptic reporting of echocardiography in carcinoid heart disease (ENETS Carcinoid Heart Disease Task Force)
por: Hofland, Johannes, et al.
Publicado: (2021) -
Carcinoid Heart Disease and Decreased Overall Survival among Patients with Neuroendocrine Tumors: A Retrospective Multicenter Latin American Cohort Study
por: Uema, Deise, et al.
Publicado: (2019) -
Delayed Presentation of Carcinoid Heart Disease and Subsequent Modified Healthcare Delivery in the COVID-19 Era
por: Willauer, Alexandra N., et al.
Publicado: (2022) -
Health resource utilisation by patients with neuroendocrine tumours with or without carcinoid heart disease: a multinational study
por: Tanaka, Hugo, et al.
Publicado: (2020) -
Carcinoid syndrome: update on the pathophysiology and treatment
por: de Celis Ferrari, Anezka C. Rubin, et al.
Publicado: (2018)